Voloridge Investment Management’s Transmedics TMDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-6,649
Closed -$746K 1355
2025
Q3
$746K Buy
+6,649
New +$778K ﹤0.01% 1071
2025
Q2
Sell
-24,398
Closed -$1.64M 1378
2025
Q1
$1.64M Sell
24,398
-270,150
-92% -$18.6M 0.01% 987
2024
Q4
$18.4M Sell
294,548
-20,471
-6% -$1.91M 0.07% 373
2024
Q3
$49.5M Sell
315,019
-124,958
-28% -$19.3M 0.18% 159
2024
Q2
$66.3M Buy
439,977
+49,628
+13% +$5.95M 0.25% 109
2024
Q1
$28.9M Buy
390,349
+58,304
+18% +$4.81M 0.11% 253
2023
Q4
$26.2M Buy
332,045
+133,514
+67% +$8.05M 0.1% 258
2023
Q3
$10.9M Buy
198,531
+136,865
+222% +$9.85M 0.05% 443
2023
Q2
$5.18M Sell
61,666
-67,922
-52% -$5.2M 0.02% 661
2023
Q1
$9.81M Buy
129,588
+13,164
+11% +$910K 0.05% 458
2022
Q4
$7.19M Sell
116,424
-30,313
-21% -$1.61M 0.04% 533
2022
Q3
$6.13M Buy
+146,737
New +$6.38M 0.03% 584
2022
Q1
Sell
-14,258
Closed -$273K 1699
2021
Q4
$273K Sell
14,258
-26,982
-65% -$676K ﹤0.01% 1481
2021
Q3
$1.36M Sell
41,240
-11,837
-22% -$362K 0.01% 1180
2021
Q2
$1.76M Sell
53,077
-53,336
-50% -$1.48M 0.01% 1034
2021
Q1
$4.42M Buy
+106,413
New +$3.27M 0.03% 567

Other funds holding TMDX

Voloridge Investment Management's TMDX Position: Q4 2025 in Review

Voloridge Investment Management sold out of Transmedics (TMDX) in Q4 2025, closing a stake of 6,649 shares — an estimated $746K sold.

Voloridge Investment Management first reported a position in TMDX in Q1 2021 and held it in 16 quarters. The position peaked at $66.3M in Q2 2024. 428 funds tracked by Wall St. Rank hold TMDX as of Q4 2025.

  • Voloridge Investment Management reported no remaining Transmedics position as of Q4 2025 after selling out during the quarter.
  • Voloridge Investment Management sold 6,649 Transmedics shares in Q4 2025, an estimated $746K.
  • Voloridge Investment Management first reported a position in Transmedics in Q1 2021 and held it in 16 quarters.
  • Voloridge Investment Management's Transmedics position peaked at $66.3M in Q2 2024.
  • 428 funds tracked by Wall St. Rank held Transmedics as of Q4 2025.

Based on Voloridge Investment Management's 13F filing for Q4 2025, filed 17 Feb 2026.